8.35

0.00% 0.00

Eton Pharmaceuticals Inc (ETON)

Overview News Price History Option Chain Financials Discussions Forecast

Eton Pharmaceuticals Inc stock is traded at $8.35, with a volume of 47,079. It is up +0.00% in the last 24 hours and up +19.29% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Previous Close:

$8.35

Open:

$8.34

24h Volume:

47,079

Relative Volume:

0.32

Market Cap:

$218.83M

Revenue:

$32.83M

Net Income/Loss:

$2.23M

P/E Ratio:

-34.79

EPS:

-0.24

Net Cash Flow:

$9.27M

1W Performance:

-2.22%

1M Performance:

+19.29%

6M Performance:

+125.07%

1Y Performance:

+83.52%

1-Day Range:

$8.26

$8.54

1-Week Range:

$8.24

$9.12

52-Week Range:

$3.03

$9.12

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name

Eton Pharmaceuticals Inc

Sector

Healthcare (1181)

Industry

Drug Manufacturers - Specialty & Generic (88)

Phone

(847) 787-7361

Address

21925 W. FIELD PARKWAY, DEER PARK, IL

Employee

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

ETON's Discussions on Twitter

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-21	Resumed	B. Riley Securities	Buy
Jan-04-21	Reiterated	H.C. Wainwright	Buy
Sep-20-19	Initiated	B. Riley FBR	Buy
Jun-10-19	Initiated	H.C. Wainwright	Buy

Eton Pharmaceuticals Inc Stock (ETON) Latest News

Oct 31, 2024

Eton Pharmaceuticals stock hits 52-week high at $8.79 amid growth - Investing.com India

Oct 31, 2024

Oct 30, 2024

Eton Pharmaceuticals stock hits 52-week high at $8.79 amid growth By Investing.com - Investing.com South Africa

Oct 30, 2024

Craig Hallum Increases Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00 - Defense World

Oct 30, 2024

Oct 29, 2024

Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum - Yahoo Finance

Oct 29, 2024

Eton Pharmaceuticals stock target raised, keeps buy on acquisition optimism By Investing.com - Investing.com Canada

Oct 29, 2024

Oct 28, 2024

Critical Insights From Eton Pharmaceuticals Analyst Ratings: What You Need To Know - Benzinga

Oct 28, 2024

Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $15.00 at Craig Hallum - MarketBeat

Oct 28, 2024

How To Trade (ETON) - Stock Traders Daily

Oct 28, 2024

Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc. - GuruFocus.com

Oct 28, 2024

Oct 27, 2024

Short Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Grows By 62.0% - MarketBeat

Oct 27, 2024

Oct 26, 2024

Eton Pharmaceuticals sees $79,814 stock purchase by Opaleye management - Investing.com South Africa

Oct 26, 2024

Oct 25, 2024

Eton Pharmaceuticals sees $79,814 stock purchase by Opaleye management By Investing.com - Investing.com Nigeria

Oct 25, 2024

Oct 17, 2024

Learn to Evaluate (ETON) using the Charts - Stock Traders Daily

Oct 17, 2024

Oct 14, 2024

Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long - Yahoo Finance

Oct 14, 2024

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Position Reduced by Squarepoint Ops LLC - Defense World

Oct 14, 2024

Oct 09, 2024

Eton Pharmaceuticals stock hits 52-week high at $7.66 By Investing.com - Investing.com South Africa

Oct 09, 2024

3 Stocks Insiders Are Buying Heavily in October 2024, and Why - The Tokenist

Oct 09, 2024

Eton Pharmaceuticals stock hits 52-week high at $7.66 - Investing.com

Oct 09, 2024

Adrenal Crisis Market to Rise by 2034 | Eton Pharmaceuticals, Antares Pharma, and others expected to boost market - openPR

Oct 09, 2024

Opaleye Management buys Eton Pharmaceuticals shares worth $434k - Investing.com India

Oct 09, 2024

Opaleye Management Inc. Bolsters Portfolio with Strategic Acquis - GuruFocus.com

Oct 09, 2024

Oct 08, 2024

Opaleye Management buys Eton Pharmaceuticals shares worth $434k By Investing.com - Investing.com Canada

Oct 08, 2024

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Major Shareholder Opaleye Management Inc. Purchases 11,248 Shares - MarketBeat

Oct 08, 2024

Oct 07, 2024

Is Eton Pharmaceuticals (NASDAQ:ETON) A Risky Investment? - Simply Wall St

Oct 07, 2024

Q4 2024 Earnings Forecast for Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Issued By HC Wainwright - MarketBeat

Oct 07, 2024

Oct 04, 2024